Bio Path | BPTH - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Baxter International USD 6.04B 86M 2026-03
Bio Path USD -8.49M 482K 2026-03
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12